Ophthalmology · New York, NY
NPI
1467637298
Since 2007
Specialty
Ophthalmology
Code 207W00000X
Group practices
5
Medicare group memberships
Hospitals
2
Hospital affiliations
222 E 41st St
New York, NY, 10017
Phone (212) 263-2573
Groups this clinician bills Medicare through
Medicare paid, 2024
$138K
1,572 services
Medicare patients, 2024
295
Average age 74
Drug cost, 2024
$526K
1,046 prescriptions
Company payments, 2025
$91K
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Himani Goyal was code 99214 (office e&m - established), 284 times for 175 patients. In total Himani Goyal billed 1,572 services in 55 codes, and Medicare paid $138K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-08-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 284 | 175 | $112.43 | $32K |
| 92134 Computerized Ophthalmic Imaging | Office | 171 | 142 | $33.98 | $5,811 |
| 92025 Test - Miscellaneous | Office | 129 | 109 | $30.12 | $3,886 |
| 92020 Ophthalmological E&M | Office | 115 | 105 | $23.53 | $2,706 |
| 92285 Standard X-ray | Office | 114 | 65 | $19.39 | $2,211 |
| 68841 Eye | Office | 89 | 53 | $14.50 | $1,291 |
| 92136 Ultrasound - Nonspecific | Office | 79 | 79 | $16.57 | $1,309 |
| 92083 Vision, Hearing, and Speech Services | Office | 70 | 55 | $52.76 | $3,693 |
| 92133 Computerized Ophthalmic Imaging | Office | 61 | 50 | $27.25 | $1,662 |
| 92250 Angiography | Office | 61 | 61 | $30.19 | $1,842 |
| 66984 Cataract Surgery | Office | 60 | 38 | $468.45 | $28K |
| 92012 Ophthalmological E&M | Office | 52 | 40 | $66.97 | $3,483 |
| 92014 Ophthalmological E&M | Office | 49 | 46 | $92.97 | $4,555 |
| 99204 Office E&M - New | Office | 32 | 32 | $136.58 | $4,370 |
| 99213 Office E&M - Established | Office | 26 | 24 | $69.50 | $1,807 |
By year: 2022 $118K for 1,333 services; 2023 $81K for 885 services; 2024 $138K for 1,572 services.
Medicare prescription drug claims, 2024
In 2024, the drug Himani Goyal prescribed most often to Medicare patients was Ketorolac Tromethamine, with 221 prescriptions and refills. In total Himani Goyal wrote 1,046 Medicare prescriptions that cost $526K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ketorolac Tromethamine Generic | 221 | 226 | 91 | $3,313 |
| Xdemvy Lotilaner | 118 | 166 | 108 | $217K |
| Latanoprost Generic | 104 | 175 | 33 | $1,129 |
| Restasis Cyclosporine | 98 | 170 | 36 | $81K |
| Prednisolone Acetate Generic | 86 | 158 | 47 | $3,289 |
| Bromfenac Sodium Generic | 55 | 75 | 29 | $12K |
| Xiidra Lifitegrast | 33 | 55 | 11 | $37K |
| Brimonidine Tartrate Generic | 32 | 62 | 12 | $577 |
| Prolensa Bromfenac Sodium | 32 | 39 | 19 | $11K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 30 | 68 | 14 | $734 |
| Timolol Maleate Generic | 23 | 49 | Under 11 | $1,759 |
| Tyrvaya Varenicline Tartrate | 20 | 20 | Under 11 | $13K |
| Valacyclovir Valacyclovir Hcl | 18 | 35 | Under 11 | $731 |
| Moxifloxacin Moxifloxacin Hcl | 18 | 18 | 14 | $252 |
| Acyclovir Generic | 14 | 14 | Under 11 | $87.4 |
Brand drugs: 534 claims; generic drugs: 512 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Himani Goyal $91K ($91K in general payments such as food, travel and fees) from 10 companies. The largest payer was Tarsus Pharmaceuticals, Inc. with $72K.
| Company | Payments | Amount |
|---|---|---|
| Tarsus Pharmaceuticals, Inc. TARS | 58 | $72K |
| Glaukos Corporation GKOS | 8 | $15K |
| Bausch & Lomb Americas Inc. BLCO | 3 | $2,632 |
| Harrow Eye, LLC | 10 | $567 |
| Abbvie Inc. ABBV | 4 | $217 |
| Mallinckrodt Hospital Products Inc. | 1 | $149 |
| Sight Sciences, Inc. SGHT | 1 | $127 |
| Alcon Vision LLC ALC | 1 | $108 |
| Ocular Therapeutix, Inc. OCUL | 2 | $41.81 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 1 | $30.79 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.